ArticleMultiple sclerosis and related disorders2022

Humoral response to COVID-19 vaccination in MS patients on disease modifying therapy: Immune profiles and clinical outcomes.

Kathryn B Holroyd et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.